Menu

Search

Joel Lexchin

Joel Lexchin

Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto

Dr. Lexchin has been writing and publishing about pharmaceutical policy issues for the past 30 years. He is the author or co-author of over 140 peer-reviewed papers on a wide range of topics in this area, including: drug regulation, pharmacosurveillance, drug promotion, research and development, access to medications in developing countries and physician prescribing behaviour. He has been a consultant on these and other issues to the Ontario provincial government, various parts of the Canadian federal government, the government of New Zealand, the Australian National Prescribing Service and the World Health Organization.

High drug prices in Canada are just one side of a bad equation

Jul 18, 2023 07:59 am UTC| Insights & Views

The Canadian health-care system is under pressure as service levels decline while costs escalate. Drugs are one of our largest health-care expenditures. A federal agency, the Patented Medicine Prices Review Board (PMPRB),...

Opioid marketing to Canadian doctors hyped benefits, downplayed harms

Mar 10, 2020 11:54 am UTC| Health

Between January 2016 and June 2019 there were over 13,900 deaths from opioid overdoses in Canada, 4,500 of which occurred in 2018. Based on information to date, 2019 is likely to have a similar mortality rate. Most deaths...

Leave the patchwork to the quilts: The case for pharmacare

Aug 26, 2019 04:23 am UTC| Insights & Views Health

On August 15, 2019, more than 1,200 academics, including me, with expertise in health care signed a letter to the leaders of Canadas federal political parties. The letter called on them to commit to a national pharmacare...

Health Canada and Big Pharma: Too close for comfort

Aug 15, 2019 17:54 pm UTC| Insights & Views Business

Over the past few decades its become common practice for drug companies and drug regulators, such as Health Canada, to sit down together at what are called pre-submission meetings. These are get-togethers where both...

Why Big Pharma must disclose payments to patient groups

Jan 14, 2019 10:58 am UTC| Insights & Views Health Business Law

A United States congressional report revealed last year that five opioid manufacturers made more than $10 million in payments to patient advocacy groups and professional societies between 2012 and 2017. Initiatives from...

We need answers to the thalidomide tragedy – to ensure drug safety today

Oct 28, 2018 13:25 pm UTC| Insights & Views Health

In 2015, after decades of fruitless lobbying, Canadian survivors of thalidomide finally received compensation from the federal government. The drug was a supposedly mild sleeping pill, a wonder drug that helped pregnant...

NAFTA negotiations may threaten pharmacare

Sep 10, 2018 13:50 pm UTC| Insights & Views Health

Around 91 per cent of Canadians want a national pharmacare plan, according to a recent national poll, so they dont have to choose between buying groceries or paying for drugs to keep them healthy. The same public...

1 2 

Economy

Oil Prices Fall on U.S.-Iran Hormuz Deal Hopes

Oil prices fell on Friday, ending a two-day rally as traders weighed reports that the United States and Iran were discussing a phased agreement that could eventually reopen the Strait of Hormuz and ease disruptions to...

Canadian Dollar Faces Pressure as Fed-BoC Policy Gap Widens

The Canadian dollar could remain under pressure through the end of 2026 as diverging monetary policy between the Federal Reserve and Bank of Canada weighs on the currency, according to CIBC Capital Markets. CIBC expects...

Japanese Yen Rebounds as Trump Flags Currency Weakness

The Japanese yen ended a five-day losing streak on Friday, rebounding from the closely watched 160-per-dollar level after Tokyo disclosed that U.S. President Donald Trump had raised concerns about the currencys weakness...

US Comfortable With Canada Trade Standoff as Import Bans Loom

President Donald Trumps administration is prepared to maintain its escalating trade dispute with Canada as new import restrictions approach and Washington threatens additional tariffs on key Canadian industries. U.S. Trade...

Dollar Falls as Oil Eases, Yen Jumps on Intervention Signals

The U.S. dollar weakened on Friday as oil prices retreated, although the currency remained headed for a second consecutive weekly gain as expectations for another Federal Reserve rate hike increased. The Japanese yen,...

Politics

Colombia Extradites FARC Dissident Leader ‘Spider’ to US

Colombia has extradited Geovany Andres Rojas, a senior commander of a dissident faction linked to the former FARC rebel movement, to the United States, where he is wanted on drug-trafficking charges. Rojas, widely known by...

Evan Gershkovich Says FSB Set Trap for 2023 Russia Arrest

Wall Street Journal reporter Evan Gershkovich says Russias Federal Security Service orchestrated an elaborate sting operation that led to his 2023 arrest on espionage charges, according to his first detailed published...

Saudi Arabia Seeks Military Support as Houthi Attacks Escalate

Saudi, Turkish and Pakistani military chiefs were expected to discuss support for Saudi Arabia as escalating Houthi attacks intensify security concerns across the Middle East, while new restrictions on Iranian flights add...

Putin Says Ukraine Peace Proposals Remain on Table

Russian President Vladimir Putin said Friday that proposals aimed at ending the 4-1/2-year war in Ukraine remain under consideration, although Moscow must determine which options best serve Russias interests. Speaking to...

Iran Rejects Nuclear Concessions in Hormuz Deal

Iran will not compromise on its nuclear rights even if the United States accepts Tehrans proposal for reopening the Strait of Hormuz, according to a senior Iranian official, underscoring major obstacles to ending the...

Science

Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028

Blue Origin is facing a significant setback after a dramatic explosion involving its New Glenn rocket severely damaged a launch pad at Cape Canaveral, Florida. According to NASA Administrator Jared Isaacman, repairs to the...

Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions

Blue Origin suffered a major setback after its uncrewed New Glenn rocket exploded during a launch pad test in Florida on Thursday, raising new challenges for Jeff Bezos space company as it competes with Elon Musks SpaceX...

SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO

SpaceX on Thursday postponed the highly anticipated launch of its 12th Starship rocket test from Texas after technical issues interrupted the final countdown. The company now plans to attempt the Starship V3 launch again...

Trump Administration Releases New UFO Files and Apollo Mission Records

The U.S. Defense Department has released dozens of previously classified UFO-related files following an order from President Donald Trump, sparking renewed debate over unidentified anomalous phenomena (UAP) and government...

China vs. NASA: The New Moon Race and What's at Stake by 2030

The space race is back and this time, its a direct competition between the United States and China for dominance on the lunar surface. NASAs Artemis II mission recently made history when four astronauts flew farther into...

Technology

AMD Hits $1 Trillion as BofA Raises Price Target to $720

Advanced Micro Devices (NASDAQ: AMD) has joined the $1 trillion market capitalization club, and BofA Securities believes the semiconductor giant has room to climb further as artificial intelligence drives stronger demand...

US Appeals Court Upholds Anthropic AI Supply Chain Ban

A U.S. federal appeals court has upheld the Department of Wars decision to exclude Anthropic from its supply chain, handing the Trump administration a significant victory in a closely watched dispute over military use of...

Solidigm Eyes $150 Billion IPO as SK Hynix Expands AI Storage Push

SK Hynix subsidiary Solidigm is considering a U.S. initial public offering as early as next year that could value the semiconductor storage company at as much as $150 billion, according to a Reuters report on Friday. The...

Meta Found Liable in New Mexico Facebook Data Privacy Case

A New Mexico jury has found Meta Platforms liable for misleading consumers about Facebook user privacy and data-sharing practices in a case tied to the Cambridge Analytica scandal. The verdict followed a two-week trial in...

DaVoice Sues Perplexity AI Over Trade Secrets

AI technology startup DaVoice has filed a lawsuit against Perplexity AI in California federal court, accusing the artificial intelligence company of misappropriating trade secrets connected to wake word technology used in...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.